Arivin Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Helsinki
Business model:B2B

Arivin Therapeutics is a biotechnology startup in Finland developing therapies to address drug-resistant bacterial infections.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 3.5M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Arivin Therapeutics

Name Criteria
Sweden Pila Pharma
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Vaxxel
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Netherlands CimCure
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Mable
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Torskal
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom BDD
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Deemea
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France HuntX Pharma
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Ireland Ovagen
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top